SEC Form 4 · accession 0001209191-17-019943
PLUS THERAPEUTICS, INC. · CNSY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Marc H Hedrick
Officer — President and CEO · Director
Period of report
Mar 8, 2017
Accepted (ET)
Mar 10, 2017 · 5:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001095981
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F1 | $1.55 | Mar 8, 2017 | A | 130,200 | A | — | Mar 8, 2027 | Common Stock | 130,200 | 130,200 | D |
Explanation of responses
- F1Option shares shall vest and become exercisable over four (4) years in forty-eight consecutive monthly installments.